ASB10
Basic information
Region (hg38): 7:151175698-151187832
Previous symbols: [ "GLC1F" ]
Links
Phenotypes
GenCC
Source:
- glaucoma 1, open angle, F (Limited), mode of inheritance: Unknown
- glaucoma 1, open angle, F (Limited), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Glaucoma 1, open angle, F | AD | Ophthalmologic | Open-angle glaucoma is typically asymptomatic until late stages, when irreversible nerve damage has already taken place; Agents that may contribute to glaucoma should be avoided | Ophthalmologic | 22156576 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASB10 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 15 | |||||
missense | 47 | 11 | 10 | 68 | ||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 2 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 17 | 20 | ||||
Total | 0 | 0 | 49 | 23 | 34 |
Variants in ASB10
This is a list of pathogenic ClinVar variants found in the ASB10 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
7-151175959-A-G | Benign (Jun 26, 2018) | |||
7-151176130-A-C | Uncertain significance (-) | |||
7-151176159-G-A | Benign (Jan 02, 2024) | |||
7-151176164-G-A | not specified | Uncertain significance (Oct 20, 2023) | ||
7-151176197-C-A | Uncertain significance (Dec 19, 2021) | |||
7-151176198-T-C | Glaucoma 1, open angle, F | not provided (-) | ||
7-151176210-G-T | not specified | Conflicting classifications of pathogenicity (Jun 23, 2023) | ||
7-151176216-G-A | not specified | Uncertain significance (Jan 05, 2024) | ||
7-151176244-C-T | Glaucoma 1, open angle, F | Benign/Likely benign (Jan 18, 2024) | ||
7-151176251-G-C | not specified | Uncertain significance (Jul 26, 2022) | ||
7-151176251-G-T | not specified | Uncertain significance (Aug 19, 2023) | ||
7-151176270-A-G | Uncertain significance (Jul 28, 2021) | |||
7-151176479-C-T | Likely benign (Aug 25, 2018) | |||
7-151176521-A-G | Benign (Jun 26, 2018) | |||
7-151176537-C-G | Likely benign (Jun 26, 2018) | |||
7-151176577-G-T | Benign (Jan 22, 2024) | |||
7-151176584-C-A | ASB10-related disorder | Likely benign (May 28, 2019) | ||
7-151176592-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
7-151176613-C-T | not specified | Likely benign (Jul 12, 2022) | ||
7-151176614-AAC-A | Uncertain significance (Nov 15, 2023) | |||
7-151176626-G-A | Likely benign (Sep 11, 2023) | |||
7-151176641-G-C | not specified | Uncertain significance (Jan 10, 2023) | ||
7-151176643-T-A | not specified | Uncertain significance (May 30, 2022) | ||
7-151176649-G-A | ASB10-related disorder | Benign (Nov 14, 2021) | ||
7-151176667-G-A | Benign (Jan 15, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ASB10 | protein_coding | protein_coding | ENST00000420175 | 5 | 12135 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
2.64e-12 | 0.0204 | 125530 | 1 | 125 | 125656 | 0.000501 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.319 | 321 | 305 | 1.05 | 0.0000207 | 2920 |
Missense in Polyphen | 82 | 77.583 | 1.0569 | 815 | ||
Synonymous | -0.215 | 138 | 135 | 1.02 | 0.00000895 | 1070 |
Loss of Function | -0.320 | 17 | 15.6 | 1.09 | 9.15e-7 | 165 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00128 | 0.00122 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00341 | 0.00332 |
Finnish | 0.000731 | 0.000647 |
European (Non-Finnish) | 0.000197 | 0.000185 |
Middle Eastern | 0.00341 | 0.00332 |
South Asian | 0.000169 | 0.000163 |
Other | 0.000499 | 0.000489 |
dbNSFP
Source:
- Function
- FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.;
- Disease
- DISEASE: Glaucoma 1, open angle, F (GLC1F) [MIM:603383]: A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. {ECO:0000269|PubMed:22156576}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.0970
Intolerance Scores
- loftool
- 0.786
- rvis_EVS
- 0.2
- rvis_percentile_EVS
- 67.46
Haploinsufficiency Scores
- pHI
- 0.139
- hipred
- N
- hipred_score
- 0.170
- ghis
- 0.530
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0449
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | High |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Asb10
- Phenotype
- hematopoietic system phenotype;
Gene ontology
- Biological process
- protein ubiquitination;intracellular signal transduction;post-translational protein modification
- Cellular component
- nucleus;cytoplasm;cytosol
- Molecular function